Literature DB >> 4292247

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

R Cash, A J Brough, M N Cohen, P S Satoh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4292247     DOI： 10.1210/jcem-27-9-1239

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  39 in total

1.  Treatment of an adrenal cortical carcinoma with a combination of o,p'-DDD and aminoglutethimide.

Authors:  R D Scott
Journal:  Postgrad Med J       Date:  1975-01       Impact factor: 2.401

Review 2.  Clinical pharmacokinetics of aromatase inhibitors and inactivators.

Authors:  Per Lønning
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 4.  Aromatase inhibitors: past, present and future in breast cancer therapy.

Authors:  Udayan Dutta; Kartikeya Pant
Journal:  Med Oncol       Date:  2007-11-01       Impact factor: 3.064

Review 5.  Aromatase inhibitors for breast cancer.

Authors:  Susanne Briest; Nancy E Davidson
Journal:  Rev Endocr Metab Disord       Date:  2007-09       Impact factor: 6.514

6.  The treatment of ACTH Paraneoplastic syndrome with aminoglutethimide.

Authors:  C B Vaughn; S Pearson; J Chapman; B Chinn; D Banks
Journal:  J Natl Med Assoc       Date:  1979-01       Impact factor: 1.798

Review 7.  The role of aromasin in the hormonal therapy of breast cancer.

Authors:  Magdolna Dank
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

8.  High-performance liquid chromatographic assay for simultaneous estimation of aminoglutethimide and acetylaminoglutethimide in biological fluids.

Authors:  A M Adam; I D Bradbrook; H J Rogers
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 9.  Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.

Authors:  R J Santen
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

10.  Aminoglutethimide treatment in advanced breast cancer: an efficient therapy as a late endocrine alternative in a sequential therapeutic approach.

Authors:  S Kvinnsland; O Dahl
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.